Items 291 to 300 of 465 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ropivacaine Hydrochloride Monohydrate | 132112-35-7 | sc-208314 sc-208314A | 10 mg 100 mg | $84.00 $408.00 | ||
Ropivacaine Hydrochloride Monohydrate serves as a chiral reagent distinguished by its unique amide structure, which facilitates hydrogen bonding and dipole-dipole interactions. The presence of a stereogenic center enhances its ability to influence reaction pathways, promoting selective formation of enantiomers. Its solubility characteristics and ability to form stable complexes with various substrates contribute to its effectiveness in asymmetric transformations, optimizing reaction rates and selectivity. | ||||||
CP 96345 | 132746-60-2 | sc-361160 sc-361160A | 5 mg 25 mg | $340.00 $849.00 | 1 | |
CP 96345 is a chiral reagent characterized by its distinctive carbonyl functionality, which engages in strong π-stacking interactions and facilitates nucleophilic attack. Its unique steric environment allows for selective binding to chiral catalysts, enhancing enantioselectivity in reactions. The compound's reactivity as an acid halide promotes rapid acylation processes, while its ability to stabilize transition states contributes to improved reaction kinetics in asymmetric synthesis. | ||||||
(S,S)-Jacobsen′s catalyst | 135620-04-1 | sc-250918 sc-250918A | 1 g 5 g | $46.00 $143.00 | ||
(S,S)-Jacobsen's catalyst is a chiral reagent notable for its ability to form stable complexes with substrates through hydrogen bonding and π-π interactions. This catalyst features a well-defined chiral pocket that directs the approach of reactants, leading to high enantioselectivity. Its unique coordination chemistry allows for efficient activation of substrates, while its robust framework enhances the stability of intermediates, optimizing reaction pathways in asymmetric transformations. | ||||||
(S)-6-Methoxy-2,5,7,8-tetramethylchromane-2-carboxylic acid | 135806-59-6 | sc-253526 | 50 mg | $133.00 | ||
(S)-6-Methoxy-2,5,7,8-tetramethylchromane-2-carboxylic acid serves as a chiral reagent characterized by its ability to engage in selective hydrogen bonding and steric interactions. Its unique chromane structure facilitates the formation of chiral environments that influence reaction kinetics, promoting enantioselective outcomes. The compound's hydrophobic regions enhance substrate solubility, while its carboxylic acid functionality can participate in key acid-base interactions, further refining reaction pathways in asymmetric synthesis. | ||||||
(R,R)-Et-DUPHOS-Rh | 136705-77-6 | sc-224248 sc-224248A | 50 mg 250 mg | $53.00 $285.00 | ||
(R,R)-Et-DUPHOS-Rh is a chiral reagent notable for its ability to form stable metal-ligand complexes, which significantly enhance catalytic activity in asymmetric transformations. The unique bidentate phosphine ligand structure allows for precise spatial arrangement, promoting selective coordination with substrates. This configuration leads to distinct reaction pathways and improved enantioselectivity, while its robust electronic properties facilitate efficient electron transfer during catalytic cycles. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $39.00 $90.00 $120.00 | 4 | |
Valsartan, as a chiral reagent, exhibits unique stereochemical properties that influence its interactions in asymmetric synthesis. Its specific molecular architecture allows for selective binding to chiral centers, enhancing reaction kinetics and promoting enantioselective outcomes. The compound's ability to stabilize transition states through non-covalent interactions, such as hydrogen bonding and π-π stacking, further optimizes reaction pathways, making it a valuable tool in chiral synthesis. | ||||||
Levofloxacin Hemihydrate | 138199-71-0 | sc-211735 | 100 mg | $191.00 | 2 | |
Levofloxacin Hemihydrate, as a chiral reagent, showcases distinctive stereochemical characteristics that facilitate its role in asymmetric transformations. Its unique spatial arrangement enables preferential interactions with chiral substrates, leading to enhanced selectivity in enantioselective reactions. The compound's capacity to form robust hydrogen bonds and engage in hydrophobic interactions contributes to its effectiveness in stabilizing intermediates, thereby influencing reaction dynamics and pathways in synthetic applications. | ||||||
NAP 226-90 | 139306-10-8 | sc-219332 | 1 mg | $180.00 | ||
NAP 226-90, as a chiral reagent, exhibits remarkable selectivity in asymmetric synthesis due to its unique steric and electronic properties. Its ability to form transient complexes with substrates enhances enantioselectivity, while its specific conformational flexibility allows for tailored interactions. The compound's reactivity as an acid halide facilitates efficient acylation processes, promoting distinct reaction pathways that can significantly influence product distribution and kinetics in various synthetic scenarios. | ||||||
(R)-6-Methoxy-2,5,7,8-tetramethylchromane-2-carboxylic acid | 139658-04-1 | sc-229123 | 50 mg | $123.00 | ||
(R)-6-Methoxy-2,5,7,8-tetramethylchromane-2-carboxylic acid serves as a chiral reagent characterized by its distinctive steric hindrance and electronic configuration, which promote high enantioselectivity in reactions. Its unique molecular architecture enables effective hydrogen bonding and π-π stacking interactions with substrates, enhancing reaction rates. Additionally, the compound's ability to stabilize transition states contributes to its efficiency in catalyzing asymmetric transformations, making it a versatile tool in synthetic chemistry. | ||||||
2,2′-Isopropylidenebis[(4S)-4-tert-butyl-2-oxazoline] | 131833-93-7 | sc-251824 | 250 mg | $130.00 | ||
2,2'-Isopropylidenebis[(4S)-4-tert-butyl-2-oxazoline] serves as a chiral reagent, distinguished by its dual oxazoline units that facilitate selective coordination with metal catalysts. The bulky tert-butyl groups create a unique steric environment, enhancing chiral induction and influencing reaction pathways. Its capacity to form stable chelates with substrates promotes favorable transition states, optimizing reaction rates and enantioselectivity in asymmetric transformations. | ||||||